共 320 条
[1]
Bajetta E(2007)Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study Br J Cancer 96 439-444
[2]
Di Bartolomeo M(2002)Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer J Clin Oncol 20 3617-3627
[3]
Buzzoni R(2004)Irinotecan (CPT-11) combined with UFT as first line treatment of advanced colorectal carcinoma-A phase II study J Clin Oncol (meeting abstracts) 22 305-4875
[4]
Mariani L(2005)Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale J Clin Oncol 23 4866-345
[5]
Zilembo N(2004)Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337-1418
[6]
Ferrario E(1998)Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 1413-301
[7]
Lo Vullo S(2007)Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer Br J Cancer 97 297-1047
[8]
Aitini E(2000)Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041-3616
[9]
Isa L(2002)Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer J Clin Oncol 20 3605-4786
[10]
Barone C(2007)Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C study J Clin Oncol 25 4779-214